Skip to content
Home/Companies/Healthcare/Envision Pharma
EP

Envision Pharma

Healthcare·UK·Exited 2021·Held 5yr

Envision Pharma is a healthcare company, headquartered in United Kingdom.

Entry
2016
Hold
5yr
Exit
2021
Est. EV
–

Who owns Envision Pharma?

Envision Pharma was owned by Ardian through Ardian Buyout Fund VI (2016 vintage) from 2016 to 2021, exited via Secondary.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Ardian
Investor
Ardian
Ardian Buyout Fund VI · 2016 · Buyout

Key facts

HQUnited Kingdom
SectorHealthcare
Exit Type
Secondary
Buyer
MOIC
–
Exit Year
2021

More from Ardian Buyout Fund VI

Other portfolio companies in the same fund.

Solina
Exited 2021
ConsumerFrance· 2018
to
D & B audiotechnik
Exited 2023
TMTGermany· 2016
Dedalus
Active
HealthcareItaly· 2016
Kersia
Exited 2020
HealthcareFrance· 2016
to
Trigo
Exited 2026
Business ServicesFrance· 2016
to
Weber Automotive
Exited 2019
IndustrialsGermany· 2016

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
Active
Advent InternationalUS
Data refreshed weekly · Sourced from public filings